ArticleNeuroradiology2026
A predictive model for differentiating PFA and PFB subtypes of posterior fossa ependymoma using multi-sequence MRI radiomics: a two-center study.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeTo evaluate radiomics machine learning (RML) models using different magnetic resonance imaging (MRI) sequences for differentiating posterior fossa A (PFA) and posterior fossa B (PFB) subtypes of posterior cranial fossa ependymoma, classified according to the latest pathological guidelines, and to perform model interpretability analyses.
methodsClinical and radiological data from 124 patients diagnosed with ependymoma in the posterior cranial fossa were retrospectively collected from two separate institutions. Radiomics features were subsequently derived from MRI sequences including T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and T2-weighted fluid-attenuated inversion recovery (T2W-FLAIR). Radiomics analyses encompassed three primary phases: feature dimension reduction, construction of feature labels, and statistical differentiation. A prediction model was subsequently developed utilizing logistic regression (LR) with min-max normalization. The performance of this model was evaluated by calculating the area under the curve (AUC), assessing calibration curves (CC), and employing decision curve analysis (DCA). Additionally, Shapley Additive Explanations (SHAP) were utilized to clarify the relationship between radiomics features and biological properties, thereby improving interpretability of the model.
resultsThe diagnostic performance of the fusion model was superior to that of single-sequence models. Specifically, the T1WI + T2W-FLAIR fusion model demonstrated optimal diagnostic efficacy in differentiating PFA and PFB subtypes of posterior cranial fossa ependymoma, with robust internal/external test set (AUC = 0.736/0.756) and high training accuracy (AUC = 0.916). SHAP analysis ranked the nine most discriminative radiomics features from the T1WI + T2W-FLAIR fusion model, reflecting their relative contribution to subtype classification.
conclusionRML models based on multiple MRI sequences can effectively differentiate PFA and PFB subtypes of posterior cranial fossa ependymoma. The T1WI + T2W-FLAIR fusion model provides higher diagnostic accuracy and can offer valuable diagnostic insights for radiologists.
Indexed as
Identifiers
41128868What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.